Ligustilide, a major bioactive component of Angelica sinensis, promotes bone formation via the GPR30/EGFR pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-43518-7.pdf
Reference54 articles.
1. Shan, P. F., Xian, C. J., Li, M., Xiang, G. D. & Yuan, L. Q. Osteoporosis. Int J Endocrinol 2013, 952858, https://doi.org/10.1155/2013/952858 (2013).
2. Tu, K. N. et al. Osteoporosis: A Review of Treatment Options. P T 43, 92–104 (2018).
3. Luo, J. et al. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption. Nat Med 22, 539–546, https://doi.org/10.1038/nm.4076 (2016).
4. Manolagas, S. C. & Jilka, R. L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332, 305–311, https://doi.org/10.1056/NEJM199502023320506 (1995).
5. Hendrickx, G., Boudin, E. & Van Hul, W. A look behind the scenes: the risk and pathogenesis of primary osteoporosis. Nat Rev Rheumatol 11, 462–474, https://doi.org/10.1038/nrrheum.2015.48 (2015).
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Z-ligustilide provides a neuroprotective effect by regulating the phenotypic polarization of microglia via activating Nrf2-TrxR axis in the Parkinson's disease mouse model;Redox Biology;2024-10
2. Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis;Frontiers in Pharmacology;2024-08-08
3. Pharmacokinetic and tissue distribution analysis of bioactive compounds from Fuke Qianjin capsules in rats by a validated UPLC MS/MS method;Journal of Pharmaceutical and Biomedical Analysis;2024-06
4. Construction of microgravity biological knowledge graph and its applications in anti-osteoporosis drug prediction;Life Sciences in Space Research;2024-05
5. Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity;Frontiers in Pharmacology;2024-04-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3